Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial ...

Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety ...
Medical Dialogues

Bayer begins Phase III study with Mirena for nonatypical endometrial hyperplasia

Berlin: Bayer has announced the clinical Phase III study SUNFLOWER with its 52mg levonorgestrel-releasing intrauterine system ...